InsidersTradesSigma
Follow the Embla Medical hf share price and the full directors' dealings record of the company, a publicly traded company based in Denmark. Shares trade on the DK market, under the supervision of Finanstilsynet DK. Operating in the Health Care sector, Embla Medical hf has published 6 insider filings. Market capitalisation: €11.4bn. The latest transaction was disclosed on 28 May 2018 (Other). The full history is openly available.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Embla Medical hf Buy (bullish), based on 5 analysts. Average price target: DKK 33.50.
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,984 of 29,053 companies
51.2
score / 100
Value40
Quality62
FCF yld0.9%
Earn yld0.7%
EV/EBITDA·
ROE11%
Gross mgn62%
Net mgn9.0%
Debt/EBITDA2.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 May 2018
About Embla Medical hf
Embla Medical hf is a company focused on the healthcare and pharmaceutical sector, providing innovative solutions for the diagnosis and treatment of sleep disorders. It is listed on the XCSE exchange.